BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 27
• 28
• 29
• 30

• Drug Development

  H. Lundbeck A/S Says Clobazam Effective In Seizures in Phase 3 Study

  December 6, 2010

   · 

  7 min read
• Business

  Sangart, Inc. Announces Cooperative Research and Development Agreement With the U.S. Navy to Evaluate MP4 Molecule in Traumatic Brain Injury

  December 6, 2010

   · 

  2 min read
• Genetown

  InVivo Therapeutics Corporation Closes Oversubscribed Private Placement, Raising $13 Million

  December 6, 2010

   · 

  4 min read
• Drug Development

  Sunovion Pharmaceuticals Inc. Release: New STEDESA(TM) Clinical Data Presented at American Epilepsy Society Annual Meeting

  December 6, 2010

   · 

  1 min read
• Drug Development

  Biocryst Pharmaceuticals Reports New Data from Its Phase 2 Forodesine Study in Patients with Chronic Lymphocytic Leukemia at the 52nd Annual American Society of Hematology Meeting

  December 6, 2010

   · 

  1 min read
• Drug Development

  Phase III Data Published in Lancet Show Novartis Pharmaceuticals Corporation Drug Zometa(R) Improves Overall Survival in Newly Diagnosed Multiple Myeloma Patients

  December 6, 2010

   · 

  12 min read
• Drug Development

  US Oncology, Inc. Research Investigators Participated in Studies That Will be Presented at the 2010 American Society of Hematology Annual Meeting and Exposition

  December 6, 2010

   · 

  4 min read
• Drug Development

  Longer-term Phase III Data Show Novartis Corporation Drug Tasigna(R) Continues to Surpass Gleevec(R)

  December 6, 2010

   · 

  25 min read
• Drug Development

  Telik, Inc. Announces Final Positive Phase 2 Results of a Multicenter Study of Oral Ezatiostat Hydrochloride (TELINTRA(R), TLK199) in Patients with Myelodysplastic Syndrome

  December 6, 2010

   · 

  12 min read
• Business

  Biodel Inc. to Report Fourth Quarter Fiscal Year 2010 Financial Results on December 9, 2010

  December 6, 2010

   · 

  1 min read